AEON BIOPHARMA INC (AEON) Stock Cash Flow
NYSEARCA:AEON - American Stock Exchange - US00791X1000 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -36.63M | 9.98M | 8.20M | 0.00 | 160.32M | |||
| Depreciation Amortization | 99.00K | N/A | N/A | 0.00 | 880.00K | |||
| Income Taxes - Deferred | N/A | 588.90K | N/A | 0.00 | -14.65M | |||
| Change In Working Capital | -2.74M | 2.64M | 441.16K | 1.45M | 50.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 3.46M | |||
| Other non cash items | -8.55M | -14.19M | -10.14M | 0.00 | -191.32M | |||
| OPERATING CASH FLOW | -47.83M | -981.43K | -1.49M | 0.00 | -44.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | N/A | N/A | 0.00 | -1.69M | |||
| Other Investing Activity | N/A | 401.93K | -276.00M | -1.27M | -115.60M | |||
| INVESTING CASH FLOW | 0.00 | 401.93K | -276.00M | -1.27M | -117.29M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 14.00M | 150.00K | -38.59K | 25.11M | 9.68M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 278.30M | 0.00 | 77.80M | |||
| Other Financing Activity | N/A | 0.00 | -269.21K | -540.00K | -14.26M | |||
| FINANCING CASH FLOW | 14.00M | 150.00K | 277.99M | 24.57M | 73.21M | |||
| CHANGE IN CASH | -33.83M | -429.50K | 497.41K | 0.00 | -88.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -47.83M | -981.43K | -1.49M | 0.00 | -44.73M | |||
| Capital Expenditure | 0.00 | N/A | N/A | 0.00 | -1.69M | |||
| FREE CASH FLOW | -47.83M | -981.43K | -1.49M | 0.00 | -46.42M | |||
All data in USD